Global Point of Care

Reinforcing the use of antigen testing to slow the COVID-19 pandemic

Slow the COVID-19 Pandemic

Monday, January 17, 2022
8:00-9:30 AM CT / 3:00-4:30 PM CET

With a focus on new variants and global surges in COVID-19 cases, the world remains on guard to respond to new guidance and potential lockdowns.

Ongoing epidemiological updates on new cases in the unvaccinated, breakthrough infections in the vaccinated, and re-infections in recovered patients have been important guideposts for action.

The diagnosis of COVID-19 includes two approaches - identifying those infected with COVID-19 and identifying those who are infectious with competent virus.

Join this webinar to hear global experts discuss the benefits, latest studies, and rationale for large-scale use of antigen testing as an essential and effective tool in our global testing arsenal.

Speakers

Michael Mina, MD, PhD — USA
Topic: Re-calibration in the use of Ag test in the fight against the COVID-19 epidemic.

Mary Rodgers, PhD — USA
Topic: The Abbott Global Surveillance Program- SARS-CoV-2 variant vigilance.

Amilcar Tanuri, MD, PhD — Brazil
Topic: High correlation of Virological confirmation on subject infected with COVID-19 when the Ag test is positive.

MODERATOR

Luis Gonzalez, MD, PhD
Global Director of Medical and Scientific Affairs - Abbott

Q&A MODERATOR

Norman Moore, PhD 
Global Director of Scientific Affairs, Infectious Diseases - Abbott

Related Webinars

The lab in the future: how COVID-19 taught us the value of a transcendent laboratory service
Transitioning to Endemic COVID-19 Testing: Evidence-Based Assessment on Current and Future Rapid Antigen Test Detection
Detecting Omicron: Evidence-Based Clinical Assessment of Rapid Antigen Testing